LPL Financial’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-17,967
| Closed | -$260K | – | 6261 |
|
|
2026
Q1 | $260K | Sell |
17,967
-17,838
| -50% | -$256K | ﹤0.01% | 5298 |
|
|
2025
Q4 | $510K | Sell |
35,805
-10,082
| -22% | -$99K | ﹤0.01% | 4697 |
|
|
2025
Q3 | $362K | Buy |
45,887
+21,470
| +88% | +$153K | ﹤0.01% | 4896 |
|
|
2025
Q2 | $140K | Buy |
24,417
+12,752
| +109% | +$82.3K | ﹤0.01% | 5187 |
|
|
2025
Q1 | $95.2K | Buy |
11,665
+180
| +2% | +$1.67K | ﹤0.01% | 5052 |
|
|
2024
Q4 | $108K | Buy |
11,485
+388
| +3% | +$4.03K | ﹤0.01% | 4979 |
|
|
2024
Q3 | $119K | Buy |
11,097
+1,001
| +10% | +$10.9K | ﹤0.01% | 4860 |
|
|
2024
Q2 | $100K | Buy |
+10,096
| New | +$104K | ﹤0.01% | 4747 |
|
|
2022
Q1 | – | Sell |
-13,941
| Closed | -$161K | – | 4263 |
|
|
2021
Q4 | $161K | Sell |
13,941
-4,672
| -25% | -$52.1K | ﹤0.01% | 4038 |
|
|
2021
Q3 | $178K | Buy |
+18,613
| New | +$190K | ﹤0.01% | 4024 |
|
|
2021
Q2 | – | Sell |
-13,035
| Closed | -$129K | – | 4251 |
|
|
2021
Q1 | $129K | Buy |
13,035
+3,118
| +31% | +$48.3K | ﹤0.01% | 3876 |
|
|
2020
Q4 | $229K | Sell |
9,917
-23,318
| -70% | -$477K | ﹤0.01% | 3421 |
|
|
2020
Q3 | $469K | Sell |
33,235
-213
| -0.6% | -$3.1K | ﹤0.01% | 2524 |
|
|
2020
Q2 | $504K | Buy |
33,448
+3,320
| +11% | +$40.5K | ﹤0.01% | 2378 |
|
|
2020
Q1 | $278K | Buy |
30,128
+19,965
| +196% | +$190K | ﹤0.01% | 2553 |
|
|
2019
Q4 | $99K | Sell |
10,163
-1,822
| -15% | -$16.7K | ﹤0.01% | 3222 |
|
|
2019
Q3 | $96K | Sell |
11,985
-887
| -7% | -$9.63K | ﹤0.01% | 3150 |
|
|
2019
Q2 | $161K | Sell |
12,872
-1,466
| -10% | -$18.6K | ﹤0.01% | 3080 |
|
|
2019
Q1 | $195K | Sell |
14,338
-895
| -6% | -$10.9K | ﹤0.01% | 2953 |
|
|
2018
Q4 | $146K | Sell |
15,233
-644
| -4% | -$7.08K | ﹤0.01% | 2897 |
|
|
2018
Q3 | $192K | Buy |
15,877
+583
| +4% | +$8.15K | ﹤0.01% | 3010 |
|
|
2018
Q2 | $239K | Sell |
15,294
-403
| -3% | -$6.09K | ﹤0.01% | 2853 |
|
|
2018
Q1 | $236K | Buy |
15,697
+151
| +1% | +$2.3K | ﹤0.01% | 2827 |
|
|
2017
Q4 | $224K | Buy |
15,546
+81
| +0.5% | +$1.11K | ﹤0.01% | 2726 |
|
|
2017
Q3 | $233K | Buy |
+15,465
| New | +$205K | ﹤0.01% | 2553 |
|
|
2017
Q1 | – | Sell |
-10,000
| Closed | -$51K | – | 2730 |
|
|
2016
Q4 | $51K | Sell |
10,000
-1,000
| -9% | -$6.92K | ﹤0.01% | 2634 |
|
|
2016
Q3 | $80K | Hold |
11,000
| – | – | ﹤0.01% | 2554 |
|
|
2016
Q2 | $62K | Sell |
11,000
-11,000
| -50% | -$76.9K | ﹤0.01% | 2545 |
|
|
2016
Q1 | $185K | Hold |
22,000
| – | – | ﹤0.01% | 2811 |
|
|
2015
Q4 | $203K | Buy |
22,000
+9,457
| +75% | +$85.2K | ﹤0.01% | 2811 |
|
|
2015
Q3 | $86K | Buy |
+12,543
| New | +$197K | ﹤0.01% | 2671 |
|
Other funds holding FOLD
LPL Financial's FOLD Position: Q2 2026 in Review
LPL Financial sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 17,967 shares — an estimated $260K sold.
LPL Financial first reported a position in FOLD in Q3 2015 and held it in 31 quarters. The position peaked at $510K in Q4 2025. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.
- LPL Financial reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- LPL Financial sold 17,967 Amicus Therapeutics shares in Q2 2026, an estimated $260K.
- LPL Financial first reported a position in Amicus Therapeutics in Q3 2015 and held it in 31 quarters.
- LPL Financial's Amicus Therapeutics position peaked at $510K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.